Finished Drug Manufacturing
For over 20 years, A & M Pharmaceutical Company LTD has also manufactured formulations of drug products to supply its licensing partners worldwide. In 1997, the Group constructed a green-field facility to support the growth of its licensing business, which today supplies over 50 markets including the US, EU and Japan. Production occurs onsite at its state-of-the-art manufacturing and packaging facilities and also throughout a network of external manufacturing service providers (CMOs). Our plant in Ireland is constantly upgraded and maintained to remain fully compliant with FDA, EMA, Swissmedic, Japanese PMDA and PIC requirements.
Confidence From Experience and Quality
Our extensive drug manufacturing experience has been built on successfully transferring over 150 projects over the last three decades. A & M Pharmaceutical Company LTD manufacturing organization supports a wide range of Chemistry, Manufacturing and Control (CMC) and regulatory activities pertaining to Good Manufacturing Practice (cGMP) production, from clinical trial material to commercial launch and supply. Robust and market-oriented production processes ensure the seamless delivery of finished, ready-to-market products that our partners can confidently launch shortly after approval. Operating a Project Management system staffed with specialists from A & M Pharmaceutical Company LTD European and American companies means that our plants are qualified sites for supply to many of the world’s largest pharmaceutical companies.
A & M Pharmaceutical Company LTD Birex Pharmaceuticals
From its facility in Dublin Ireland, A & M Pharmaceutical Company LTD manages global supply of group products to its partners worldwide, including notably Europe, the US, Japan and China.